Kodiak Sciences Analyst Price Targets

Wall Street analyst price targets and consensus rating for Kodiak Sciences (KOD).

Price Target Range — 10 Quarters

Analyst Consensus — 8 Analysts

7Buy

1Hold

Consensus RatingBuy# Analysts8Avg. Consensus PT$53Upside to Avg. PT-44.5%

Rating Trend — Last 9 Months

Recent Analyst Actions

모든 평가 보기 →

Date	Firm	Analyst	Action	Rating Change	Price Target
Sep 28, 2026	LifeSci Capital	Patrick Dolezal	PT Raise	Outperform	$85→$145
Sep 28, 2026	UBS	Michael Yee	PT Raise	Buy	$80→$120
Sep 28, 2026	HC Wainwright & Co.	Matthew Caufield	PT Raise	Buy	$58→$96
Sep 24, 2026	Goldman Sachs	Andrea Newkirk	Reinstates	Neutral	$36
Sep 17, 2026	HC Wainwright & Co.	Matthew Caufield	Maintained	Buy	$58
Aug 17, 2026	HC Wainwright & Co.	Matthew Caufield	Maintained	Buy	$58
Aug 3, 2026	JP Morgan	Anupam Rama	PT Raise	Overweight	$56→$66
May 11, 2026	Chardan Capital	Daniil Gataulin	Upgrade	Neutral→Buy	$14→$61
Mar 27, 2026	UBS	Michael Yee	PT Raise	Buy	$50→$80
Mar 27, 2026	HC Wainwright & Co.	Matthew Caufield	PT Raise	Buy	$38→$58
Feb 10, 2026	HC Wainwright & Co.	Matthew Caufield	Maintained	Buy	$38
Jan 22, 2026	HC Wainwright & Co.	Matthew Caufield	PT Raise	Buy	$26→$38
Jan 7, 2026	UBS	Michael Yee	Initiate	Buy	$50
Nov 17, 2025	Chardan Capital	Daniil Gataulin	Maintained	Neutral	$14
Nov 17, 2025	HC Wainwright & Co.	Matthew Caufield	PT Raise	Buy	$24→$26
Nov 11, 2025	HC Wainwright & Co.	Matthew Caufield	Upgrade	Neutral→Buy	$5→$24
Oct 24, 2025	JP Morgan	Anupam Rama	Upgrade	Neutral→Overweight	$15→$24
Oct 23, 2025	LifeSci Capital	Patrick Dolezal	Initiate	Outperform	$40
Oct 6, 2025	Chardan Capital	Daniil Gataulin	Maintained	Neutral	$14
Sep 25, 2025	Barclays	Gena Wang	Upgrade	Underweight→Equal-Weight	$7→$17

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
UBS Maintains Buy on Kodiak Sciences, Raises Price Target to $120

UBS analyst Michael Yee maintains Kodiak Sciences (NASDAQ:KOD) with a Buy and raises the price target from $80 to $120.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Maintains Buy on Kodiak Sciences, Raises Price Target to $96

HC Wainwright & Co. analyst Matthew Caufield maintains Kodiak Sciences (NASDAQ:KOD) with a Buy and raises the price target from $58 to $96.

Benzinga Newsdesk

PRO
Goldman Sachs Reinstates Neutral on Kodiak Sciences, Announces $36 Price Target

Goldman Sachs analyst Andrea Newkirk reinstates Kodiak Sciences (NASDAQ:KOD) with a Neutral and announces $36 price target.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on Kodiak Sciences, Maintains $58 Price Target

HC Wainwright & Co. analyst Matthew Caufield reiterates Kodiak Sciences (NASDAQ:KOD) with a Buy and maintains $58 price target.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on Kodiak Sciences, Maintains $58 Price Target

HC Wainwright & Co. analyst Matthew Caufield reiterates Kodiak Sciences (NASDAQ:KOD) with a Buy and maintains $58 price target.

Benzinga Newsdesk

PRO
JP Morgan Maintains Overweight on Kodiak Sciences, Raises Price Target to $66

JP Morgan analyst Anupam Rama maintains Kodiak Sciences (NASDAQ:KOD) with a Overweight and raises the price target from $56 to $66.

Benzinga Newsdesk

Kodiak Sciences Inc

뉴스

파트너 / 기고자

벤징가 글로벌

Kodiak Sciences Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
UBS Maintains Buy on Kodiak Sciences, Raises Price Target to $120

PRO
HC Wainwright & Co. Maintains Buy on Kodiak Sciences, Raises Price Target to $96

PRO
Goldman Sachs Reinstates Neutral on Kodiak Sciences, Announces $36 Price Target

PRO
HC Wainwright & Co. Reiterates Buy on Kodiak Sciences, Maintains $58 Price Target

PRO
HC Wainwright & Co. Reiterates Buy on Kodiak Sciences, Maintains $58 Price Target

PRO
JP Morgan Maintains Overweight on Kodiak Sciences, Raises Price Target to $66

People Also Watch

People Also Watch

Kodiak Sciences Inc

뉴스

파트너 / 기고자

벤징가 글로벌

Kodiak Sciences Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PROUBS Maintains Buy on Kodiak Sciences, Raises Price Target to $120

PROHC Wainwright & Co. Maintains Buy on Kodiak Sciences, Raises Price Target to $96

PROGoldman Sachs Reinstates Neutral on Kodiak Sciences, Announces $36 Price Target

PROHC Wainwright & Co. Reiterates Buy on Kodiak Sciences, Maintains $58 Price Target

PROHC Wainwright & Co. Reiterates Buy on Kodiak Sciences, Maintains $58 Price Target

PROJP Morgan Maintains Overweight on Kodiak Sciences, Raises Price Target to $66

People Also Watch

People Also Watch

PRO
UBS Maintains Buy on Kodiak Sciences, Raises Price Target to $120

PRO
HC Wainwright & Co. Maintains Buy on Kodiak Sciences, Raises Price Target to $96

PRO
Goldman Sachs Reinstates Neutral on Kodiak Sciences, Announces $36 Price Target

PRO
HC Wainwright & Co. Reiterates Buy on Kodiak Sciences, Maintains $58 Price Target

PRO
HC Wainwright & Co. Reiterates Buy on Kodiak Sciences, Maintains $58 Price Target

PRO
JP Morgan Maintains Overweight on Kodiak Sciences, Raises Price Target to $66